Madrigal Pharmaceuticals (MDGL) Inventory Average (2024 - 2026)
Madrigal Pharmaceuticals (MDGL) posted quarterly Inventory Average of $105.7 million for Q2 2026, up 78.09% year-over-year from $59.4 million in Q2 2025, and up 13.13% quarter-over-quarter from $93.5 million in Q1 2026.
Madrigal Pharmaceuticals (MDGL) Inventory Average (2024 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported Inventory Average for 3 consecutive years, with $105.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Inventory Average rose 78.09% year-over-year to $105.7 million; the TTM figure through Jun 2026 stood at $105.7 million (up 78.09% YoY), while the FY2025 annual figure was $54.5 million, changed N/A from the prior year.
- Inventory Average improved to $105.7 million in Q2 2026 per MDGL's latest filing, from $93.5 million in the prior quarter.
- Across five years, Inventory Average topped out at $105.7 million in Q2 2026 and bottomed at $4.0 million in Q2 2024.
- Historically, Inventory Average has averaged $52.8 million across 3 years, with a median of $59.4 million in 2025.
- Annual changes were most pronounced in 2025 — Inventory Average surged 1398.08% — and 2026, when it jumped 78.09%.
- Madrigal Pharmaceuticals' Inventory Average stood at $21.4 million in 2024, then soared by 236.95% to $72.1 million in 2025, then jumped by 46.69% to $105.7 million in 2026.
- Business Quant data shows MDGL's Inventory Average at $105.7 million in Q2 2026, $93.5 million in Q1 2026, and $72.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | 105.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 105.73 Mn |
| Mar 31, 2026 | 93.46 Mn |
| Dec 31, 2025 | 72.08 Mn |
| Sep 30, 2025 | 66.41 Mn |
| Jun 30, 2025 | 59.37 Mn |
| Mar 31, 2025 | 44.65 Mn |
| Dec 31, 2024 | 21.39 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 3.96 Mn |